Sponsorship & Speaking Engagement

CDR Life Sciences Litigation Symposium June 2019

June 19, 2019

Sofitel London St James

Greg Bell is a panelist on “Globalisation in Life Sciences: Is international arbitration the future?” and CRA is sponsoring.
For more information on this event, click here.

Related Capabilities

Gregory K. Bell
Group Vice President and Life Sciences Practice Leader

Boston
+1-617-425-3357 gbell@crai.com

Life Sciences
CRA Insights

Evidence requirements for orphan drugs

CRA’s Life Sciences Practice focuses on global policy, commercialization, and market access issues dedicated to orphan drug issues, including orphan evidence...
Disruption in Pharma
Articles

Microbiome-Based Therapeutics: Negotiating Key Development Challenges

In this article published in BioProcess International, CRA’s Brian Carpenter, Robert Broadnax, and Andrew Thomson discuss how although the microbiome sector...

Explore our thinking

Rare Disease
Speaking Engagement

November 15-18, 2021

Barcelona, Spain

World Orphan Drug Congress Europe

Looking back 10 years, the rare disease space has significantly evolved with a plethora of innovative orphan drug launches and many patients gaining access to...

See all events

CDR Life Sciences Litigation Symposium June 2019

Meet the presenters

Related Insights

Evidence requirements for orphan drugs

Microbiome-Based Therapeutics: Negotiating Key Development Challenges

Upcoming Events

World Orphan Drug Congress Europe